A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
William R. Oliver, Jennifer L. Shenk, Mike R. Snaith et al. · Proceedings of the National Academy of Sciences · 2001
The peroxisome proliferator-activated receptors (PPARs) are dietary lipid sensors that regulate fatty acid and carbohydrate metabolism. The hypolipidemic effects of the fibrate drugs and the antidiabetic effects of the glitazone drugs in humans are due to activation of the alpha (NR1C1) and gamma (NR1C3) subtypes, respectively. By contrast, the therapeutic potential of the delta (NR1C2) subtype is unknown, due in part to the lack of selective ligands. We have used combinatorial chemistry and structure-based drug design to develop a potent and subtype-selective PPARdelta agonist, GW501516. In macrophages, fibroblasts, and intestinal cells, GW501516 increases expression of the reverse cholesterol transporter ATP-binding cassette A1 and induces apolipoprotein A1-specific cholesterol efflux. When dosed to insulin-resistant middle-aged obese rhesus monkeys, GW501516 causes a dramatic dose-dependent rise in serum high density lipoprotein cholesterol while lowering the levels of small-dense low density lipoprotein, fasting triglycerides, and fasting insulin. Our results suggest that PPARdelta agonists may be effective drugs to increase reverse cholesterol transport and decrease cardiovascular disease associated with the metabolic syndrome X.
Cited by 1,046 works. doi:10.1073/pnas.091021198 Open-access PDF
Authors
- William R. Oliver
- Jennifer L. Shenk
- Mike R. Snaith
- CAROLINE S. RUSSELL
- Kelli D. Plunket
- Noni L. Bodkin
- Deborah A. Winegar
- Marcos L. Sznaidman
- Millard H. Lambert
- H. Eric Xu
- Daniel D. Sternbach
- Steven A. Kliewer
- BARBARA CALEEN HANSEN
- Timothy Mark Willson
References
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
- The RXR heterodimers and orphan receptors
- Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
- Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
- The PPARs: From Orphan Receptors to Drug Discovery
- The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
- Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
- Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
- Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism